Clonz Biotech


Developer and contract manufacturer focused on biosimilar and engineered monoclonal antibodies. Operates R&D and manufacturing facilities in Genome Valley, Hyderabad, India, offering in-house clone development, cell line engineering, process development and cGMP-enabled manufacturing for clinical and commercial supply. Core activities include mammalian (CHO) expression platform work, upstream and downstream process development, analytical characterization and aseptic fill-finish.

Industries

biopharma
biotechnology
consulting
health-care
pharmaceutical

Nr. of Employees

small (1-50)

Clonz Biotech

Block No 9, Building-9000, Plot No.7, Survey No 542, Synergy Square 2, MN Park, Genome Valley, Kolthur, Shameerpet, Medchal, Hyderabad, Pin code: 500078, India


Products

Biosimilar and biobetter monoclonal antibody pipeline

Active pipeline of monoclonal antibody candidates and biosimilars targeting oncology, autoimmune and ophthalmology therapeutic areas; internal clone/product development and manufacturing focus.


Services

End-to-end contract development and manufacturing services for monoclonal antibodies including cell line development, process development, cGMP DS manufacturing (up to 2,000 L), analytical characterization and aseptic fill–finish.

Expertise Areas

  • Monoclonal antibody (MAb) discovery and development
  • Cell line engineering and cell banking
  • Upstream and downstream bioprocess development
  • cGMP biologics manufacturing (clinical and commercial)
  • Show More (4)

Key Technologies

  • CHO-based mammalian expression
  • Recombinant DNA and vector engineering
  • Single-use bioreactors
  • Upstream cell culture and fermentation
  • Show More (6)

News & Updates

Announcement of accessible drug positioning and launch of new R&D labs in Genome Valley, Hyderabad.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.